Disseminated phaeohyphomycosis due to Ochroconis gallopavum in the setting of advanced HIV infection

Medical Mycology

Volumn 44, Issue 8, 2006, Pages 777-782

  Boggild, Andrea K ^a   Poutanen, Susan M ^a,b   Mohan, Subhash ^b   Ostrowski, Mario A ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Dematiaceous fungi; HIV; Immunodeficiency; Phaeohyphomycosis; Systemic mycoses

Indexed keywords

ANTIRETROVIRUS AGENT; AZITHROMYCIN; CANNABIS; CASPOFUNGIN; CEFTRIAXONE; COTRIMOXAZOLE; FLUCONAZOLE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TAZOBACTAM; VORICONAZOLE;

ADULT; ARTICLE; CANNABIS ADDICTION; CASE REPORT; COMMUNITY ACQUIRED PNEUMONIA; COUGHING; DIARRHEA; DYSPNEA; FLANK PAIN; FUNGUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MALE; OCHROCONIS GALLOPAVUM; PHAEOHYPHOMYCOSIS; PNEUMOCYSTIS PNEUMONIA; RISK FACTOR; SYSTEMIC MYCOSIS; THORAX PAIN;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; ASCOMYCOTA; BIOPSY; FATAL OUTCOME; HISTOCYTOCHEMISTRY; HUMANS; MALE; MARIJUANA ABUSE; MYCOSES; PYRIMIDINES; TRIAZOLES;

CANNABIS SATIVA; FUNGI; OCHROCONIS;

EID: 34547629208     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780600900098     Document Type: Article

References (34)

1. Hospenthal DR. Uncommon Fungi. In:MAndell G, Bennett J, Dolin R (eds). Principles and Practice of Infectious Diseases, 6th edn. Philadelphia: Churchill-Livingstone, 2005:3068-3079.
2. Rees, JR and Pinner, RW and Hajjeh, RA and Brandt, ME and Reingold, AL. (1998) The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: Results of population-based laboratory active surveillance Clin Infect Dis, 27, pp. 1138-1147.
3. Revankar, S and Patterson, J and Sutton, D and Pullen, R and Rinaldi, M. (2002) Disseminated phaeohyphomycosis: Review of an emerging mycosis Clin Infect Dis, 34, pp. 467-476.
4. Silveira, F and Nucci, M. (2001) Emergence of black moulds in fungal disease: Epidemiology and therapy Curr Opin Infect Dis, 14, pp. 679-684.
5. Kralovic, S and Rhodes, J. (1995) Phaeohyphomycosis caused by Dactylaria (human Dactylariosis): Report of a case with review of the literature J Infect, 31, pp. 107-113.
6. Revankar, S and Sutton, D and Rinaldi, M. (2004) Primary central nervous system phaeohyphomycosis: A review of 101 cases Clin Infect Dis, 38, pp. 206-216.
7. Mancini, MC and McGinnis, MR. (1992) Dactylaria infections of a human being: Pulmonary disease in a heart transplant recipient J Heart Lung Transplant, 11, pp. 827-830.
8. Prevost-Smith E, Hutton N, Padhye AA, Upshur JK, Van Bakel AB. Fatal phaeohyphomycotic infection due to Dactylaria gallopava and Scedosporium prolificans in a cardiac transplant. in:PRoceedings and Abstracts of the 93rd Annual Meeting of the American Society for Microbiology, Atlanta, GA, 1993. Washington: ASM Press, 1993:F-35.
9. Vukmir, RB and Kusne, S and Linden, P and (1994) Successful therapy for cerebral phaeohyphomycosis due to Dactylaria gallopava in a liver transplant recipient Clin Infect Dis, 19, pp. 714-719.
10. Burns, K and Ohori, P and Iacono, A. (2000) Dactylaria gallopava infection presenting as a pulmonary nodule in a single-lung transplant recipient J Heart Lung Transplant, 19, pp. 900-902.
11. Mazur, J and Judson, M. (2001) A case report of a Dactylaria fungal infection in a lung transplant patient Chest, 119, pp. 651-653.
12. Wang, TK and Chiu, W and Chim, S and (2003) Disseminated Ochroconis gallopavum infection in a renal transplant recipient: The first reported case and a review of the literature Clin Nephrol, 60, pp. 415-423.
13. Jenney, A and Maslen, M and Bergin, P and (1998) Pulmonary infection due to Ochroconis gallopavum treated successfully after orthotopic heart transplantation Clin Infect Dis, 26, pp. 236-237.
14. Fukushiro, KR and Udagawa, S and Kawashima, Y and Kawamura, Y. (1986) Subcutaneous abscesses caused by Ochroconis gallopavum J Med Vet Mycol, 24, pp. 175-182.
15. Terreni, AA and DiSalvo, AF and Baker, AS and (1990) Disseminated Dactylaria gallopava infection in a diabetic patient with chronic lymphocytic leukemia of the T-cell type Am J Clin Pathol, 94, pp. 104-107.
16. Sides, EH and Benson, JD and Padhye, AA. (1991) Phaeohyphomycotic brain abscesses due to Ochroconis gallopavum in a patient with malignant lymphoma of a large cell type J Med Vet Mycol, 29, pp. 317-322.
17. Fukushima, N and Mannen, K and Okamoto, S and (2005) Disseminated Ochroconis gallopavum infection in a chronic lymphocytic leukemia: A case report and review of the literature on hematological malignancies Intern Med, 44, pp. 879-882.
18. Bowyer, JD and Johnson, EM and Horn, EH and Gregson, RM. (2000) Ochroconis gallopava endophthalmitis in fludaribine treated chronic lymphocytic leukemia Br J Ophthalmol, 84, pp. 117-121.
19. Zhao, J and Wang, Z and Li, R and Wang, D and Bai, Y. (2002) Pemphigus patient with pulmonary fungal infection caused by Ochroconis gallopava: the first case report in China Zhonghua Yi Xue Za Zhi, 82, pp. 1310-1313.
20. Odell, J and Alvarez, S and Cvitkovich, D and Cortese, D and McComb, B. (2000) Multiple lung abscesses due to Ochroconis gallopavum, a dematiaceous fungus, in a nonimmunocompromised wood pulp worker Chest, 118, pp. 1503-1505.
21. Kent, D and Wong, T and Osgood, R and (1998) Fungemia due to Hormonema dematioides following intense avian exposure Clin Infect Dis, 26, pp. 759.
22. Marriott, DJ and Wong, KH and Aznar, E and (1997) Scytalidium dimidiatum and Lecythophora hoffmannii: Unusual causes of fungal infections in a patient with AIDS J Clin Microbiol, 35, pp. 2949-2952.
23. Nenoff, P and Gutz, U and Tintelnot, K and (1996) Disseminated mycosis due to Scedosporium prolificans in an AIDS patient with Burkitt lymphoma Mycoses, 39, pp. 461-465.
24. Verweij, PE and Kerremans, JJ and Voss, A and Meis, JF. (2000) Fungal contamination of tobacco and marijuana J Am Med Assoc, 284, pp. 2875.
25. Hamadeh, R and Avdehali, A and Locksley, RM and York, MK. (1988) Fatal aspergillosis associated with smoking contaminated marijuana in a marrow transplant recipient Chest, 94, pp. 432-433.
26. Marks, WH and Florence, L and Lieberman, J and (1996) Successfully treated invasive pulmonary aspergillosis associated with smoking marijuana in a renal transplant recipient Transplantation, 61, pp. 1771-1774.
27. Szyper-Kravitz, M and Lang, R and Manor, Y and Lehav, M. (2001) Early invasive pulmonary aspergillosis in a leukemia patient linked to Aspergillus contaminated marijuana smoking Leuk Lymph, 42, pp. 1433-1437.
28. McGinnis, MR and Pasarell, L. (1998) in vitro testing of susceptibilities of filamentous ascomycetes to voriconazole, itraconazole, and amphotericin B, with considerations of phylogenetic implications J Clin Microbiol, 36, pp. 2353-2355.
29. McGinnis, MR and Pasarell, L and Sutton, DA and (1997) in vitro evaluation of voriconazole against some clinically important fungi Antimicrob Agents Chemother, 41, pp. 1832-1834.
30. Johnson, LB and Kauffmann, CA. (2003) Voriconazole: A new triazole antifungal agent Clin Infect Dis, 36, pp. 630-637.
31. Espinel-Ingroff, A. (1998) Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts J Clin Microbiol, 36, pp. 2950-2956.
32. McGinnis, MR and Pasarell, L. (1998) in vitro evaluation of terbinafine and itraconazole against dematiaceous fungi Med Mycol, 36, pp. 243-246.
33. Hay, RJ. (1999) Therapeutic potential of terbinafine in subcutaneous and systemic mycoses Br J Dermatol, 141, pp. 36-40.
34. Perez, A. (1999) Terbinafine: Broad new spectrum of indications in several subcutaneous and systemic and parasitic diseases Mycoses, 42(Suppl. 2), pp. 111-114.